US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 16.780
- +0.210+1.27%
Close Nov 29 13:00 ET
- 16.780
- 0.0000.00%
Post 13:10 ET
19.01BMarket Cap-19741P/E (TTM)
16.960High16.370Low4.93MVolume16.460Open16.570Pre Close82.68MTurnover0.44%Turnover RatioLossP/E (Static)1.13BShares19.31052wk High3.13P/B18.90BFloat Cap9.35052wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM3.56%Amplitude3.107Historical Low16.758Avg Price1Lot Size
Teva Pharmaceutical Industries Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 13,740.00%692M | -67.90%104M | 14.48%-124M | -13.96%1.37B | 21.69%1.18B | -99.08%5M | 163.41%324M | -195.92%-145M | 99.25%1.59B | 113.38%973M |
| Net income from continuing operations | -606.49%-390M | 3.53%-874M | -65.61%-419M | 75.39%-615M | 134.67%467M | 32.76%77M | -249.81%-906M | 73.42%-253M | -648.03%-2.5B | -786.18%-1.35B |
| Operating gains losses | -600.00%-21M | 96.67%-1M | ---- | -510.00%-41M | -233.33%-12M | -123.08%-3M | -372.73%-30M | 117.39%4M | -90.38%10M | 280.00%9M |
| Depreciation and amortization | -8.48%259M | -13.67%259M | -10.53%272M | -11.85%1.15B | -13.07%266M | -11.84%283M | -16.20%300M | -5.88%304M | -1.65%1.31B | -4.38%306M |
| Deferred tax | 73.37%-53M | -863.64%-424M | -78.30%-189M | 70.21%-317M | -78.67%32M | -552.27%-199M | 95.94%-44M | 39.43%-106M | -786.67%-1.06B | 212.78%150M |
| Other non cash items | 160.00%3M | 5,025.00%591M | -94.12%2M | 167.03%61M | 65.38%43M | 87.50%-5M | 88.79%-12M | 13.33%34M | -450.00%-91M | -13.33%26M |
| Change In working capital | 239.65%317M | -104.72%-10M | -42.41%-497M | -105.31%-72M | -16.09%292M | -344.09%-227M | -40.11%212M | -162.43%-349M | 179.66%1.36B | 93.33%348M |
| -Change in receivables | ---- | ---- | ---- | -96.41%12M | ---- | ---- | ---- | ---- | 158.19%334M | ---- |
| -Change in inventory | ---- | ---- | ---- | 9.82%-147M | ---- | ---- | ---- | ---- | -142.89%-163M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | -21.07%1.59B | ---- | ---- | ---- | ---- | 163.35%2.01B | ---- |
| -Change in other current assets | ---- | ---- | ---- | -84.18%-1.53B | ---- | ---- | ---- | ---- | 63.54%-828M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 13,760.00%693M | -68.21%103M | 14.48%-124M | -13.96%1.37B | 21.69%1.18B | -99.08%5M | 163.41%324M | -195.92%-145M | 99.25%1.59B | 113.38%973M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 45.65%268M | -41.06%178M | -20.44%144M | 47.56%968M | 79.17%301M | 25.17%184M | 68.72%302M | 12.42%181M | -56.93%656M | -31.71%168M |
| Net PPE purchase and sale | 0.67%-148M | 18.49%-97M | 9.49%-124M | 4.01%-526M | 16.20%-119M | -22.13%-149M | 6.30%-119M | -3.79%-137M | 2.49%-548M | 7.19%-142M |
| Net business purchase and sale | 280.00%38M | -98.21%1M | ---15M | 11.48%68M | --0 | 400.00%10M | 211.11%56M | --0 | -80.39%61M | -45.24%23M |
| Net investment purchase and sale | 202.63%39M | -2,050.00%-43M | -200.00%-12M | -1,633.33%-46M | -140.00%-2M | -2,000.00%-38M | -166.67%-2M | 0.00%-4M | -97.60%3M | 145.45%5M |
| Net other investing changes | ---- | ---- | ---- | ---5M | --1M | -133.33%-1M | -100.00%-4M | 0.00%-1M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 45.65%268M | -41.06%178M | -20.44%144M | 47.56%968M | 79.17%301M | 25.17%184M | 68.72%302M | 12.42%181M | -56.93%656M | -31.71%168M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -1,656.36%-966M | 78.61%-151M | -28.65%-1.91B | 18.99%-576M | -30.91%-576M | 83.73%-55M | -35,400.00%-706M | 31.54%-1.49B | -41.92%-711M |
| Net issuance payments of debt | --0 | ---956M | --0 | -24.25%-1.7B | 29.38%-500M | -36.99%-500M | --0 | ---701M | 36.80%-1.37B | -41.60%-708M |
| Net other financing activities | ---- | 81.82%-10M | -2,920.00%-151M | -79.66%-212M | -2,433.33%-76M | -2.70%-76M | -30.95%-55M | -350.00%-5M | -1,866.67%-118M | -200.00%-3M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -1,656.36%-966M | 78.61%-151M | -28.65%-1.91B | 18.99%-576M | -31.21%-576M | 83.73%-55M | -35,400.00%-706M | 31.54%-1.49B | -41.92%-711M |
| Net cash flow | ||||||||||
| Beginning cash position | -15.43%2.26B | 37.45%2.99B | 13.87%3.23B | 28.94%2.83B | -0.35%2.25B | 27.69%2.67B | -3.29%2.18B | 28.94%2.83B | 0.96%2.2B | 10.42%2.26B |
| Current changes in cash | 348.32%961M | -219.79%-684M | 80.30%-132M | -44.27%423M | 111.40%909M | -254.18%-387M | 1,686.11%571M | -687.72%-670M | 409.40%759M | 113.93%430M |
| Effect of exchange rate changes | 403.03%100M | 36.36%-49M | -966.67%-104M | 75.61%-30M | -53.42%68M | 60.71%-33M | 37.40%-77M | 119.35%12M | 3.91%-123M | 404.17%146M |
| End cash Position | 47.51%3.32B | -15.43%2.26B | 37.45%2.99B | 13.87%3.23B | 13.87%3.23B | -0.35%2.25B | 27.69%2.67B | -3.29%2.18B | 28.94%2.83B | 28.94%2.83B |
| Free cash flow | 478.47%545M | -97.07%6M | 12.68%-248M | -19.19%842M | 28.16%1.07B | -134.20%-144M | 5,225.00%205M | -37.86%-284M | 341.53%1.04B | 174.26%831M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
